Folgen
Peter Woollard
Peter Woollard
Bestätigte E-Mail-Adresse bei ebi.ac.uk
Titel
Zitiert von
Zitiert von
Jahr
An abundance of rare functional variants in 202 drug target genes sequenced in 14,002 people
MR Nelson, D Wegmann, MG Ehm, D Kessner, P St. Jean, C Verzilli, ...
Science 337 (6090), 100-104, 2012
7992012
Broadening the horizon–level 2.5 of the HUPO-PSI format for molecular interactions
S Kerrien, S Orchard, L Montecchi-Palazzi, B Aranda, AF Quinn, N Vinod, ...
BMC biology 5, 1-11, 2007
3072007
The minimum information required for reporting a molecular interaction experiment (MIMIx)
S Orchard, L Salwinski, S Kerrien, L Montecchi-Palazzi, M Oesterheld, ...
Nature biotechnology 25 (8), 894-898, 2007
2882007
Characterization of a Mycobacterium tuberculosis H37Rv transposon library reveals insertions in 351 ORFs and mutants with altered virulence
RA McAdam, S Quan, DA Smith, S Bardarov, JC Betts, FC Cook, ...
Microbiology 148 (10), 2975-2986, 2002
1492002
The application of next-generation sequencing technologies to drug discovery and development
PM Woollard, NAL Mehta, JJ Vamathevan, S Van Horn, BK Bonde, ...
Drug discovery today 16 (11-12), 512-519, 2011
762011
Minipig and beagle animal model genomes aid species selection in pharmaceutical discovery and development
JJ Vamathevan, MD Hall, S Hasan, PM Woollard, M Xu, Y Yang, X Li, ...
Toxicology and applied pharmacology 270 (2), 149-157, 2013
682013
Matching disease and phenotype ontologies in the ontology alignment evaluation initiative
I Harrow, E Jiménez-Ruiz, A Splendiani, M Romacker, P Woollard, ...
Journal of biomedical semantics 8, 1-13, 2017
632017
Ontology mapping for semantically enabled applications
I Harrow, R Balakrishnan, E Jimenez-Ruiz, S Jupp, J Lomax, J Reed, ...
Drug discovery today 24 (10), 2068-2075, 2019
592019
Deep resequencing unveils genetic architecture of ADIPOQ and identifies a novel low-frequency variant strongly associated with adiponectin variation
LL Warren, L Li, MR Nelson, MG Ehm, J Shen, DJ Fraser, JL Aponte, ...
Diabetes 61 (5), 1297-1301, 2012
492012
The European nucleotide archive in 2022
J Burgin, A Ahamed, C Cummins, R Devraj, K Gueye, D Gupta, V Gupta, ...
Nucleic Acids Research 51 (D1), D121-D125, 2023
482023
An integrated data driven approach to drug repositioning using gene-disease associations
J Mullen, SJ Cockell, P Woollard, A Wipat
PloS one 11 (5), e0155811, 2016
472016
A community standard format for the representation of protein affinity reagents
DE Gloriam, S Orchard, D Bertinetti, E Björling, E Bongcam-Rudloff, ...
Molecular & Cellular Proteomics 9 (1), 1-10, 2010
392010
Linkage analysis of 7 polymorphic markers at chromosome 11p11. 2‐11q13 in 27 multiple endocrine neoplasia type 1 families
RV Thakker, C Wooding, JT Pang, B Farren, B Harding, DC Anderson, ...
Annals of human genetics 57 (1), 17-25, 1993
381993
NIX: a nucleotide identification system at the HGMP-RC
GW Williams, PM Woollard, P Hingamp
URL: http://www. hgmp. mrc. ac. uk/NIX, 1998
321998
Mining integrated semantic networks for drug repositioning opportunities
J Mullen, SJ Cockell, H Tipney, PM Woollard, A Wipat
PeerJ 4, e1558, 2016
242016
A case study: semantic integration of gene–disease associations for type 2 diabetes mellitus from literature and biomedical data resources
D Rebholz-Schuhmann, C Grabmüller, S Kavaliauskas, S Croset, ...
Drug discovery today 19 (7), 882-889, 2014
232014
Towards virtual knowledge broker services for semantic integration of life science literature and data sources
I Harrow, W Filsell, P Woollard, I Dix, M Braxenthaler, R Gedye, D Hoole, ...
Drug discovery today 18 (9-10), 428-434, 2013
162013
Genetic variation
MR Barnes, G Breen
Humana, 2009
122009
Safety and efficacy of iron oxide black, red and yellow for all animal species
G Aquilina, G Azimonti, V Bampidis, M de Lourdes Bastos, G Bories, ...
Efsa Journal 14 (6), 1-16, 2016
112016
Asking complex questions of the genome without programming
PM Woollard
Genetic Variation: Methods and Protocols, 39-52, 2010
102010
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20